SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-18-048591
Filing Date
2018-09-07
Accepted
2018-09-07 17:13:00
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv502427_s3.htm S-3 333857
2 EXHIBIT 4.1 tv502427_ex4-1.htm EX-4.1 414598
3 EXHIBIT 5.1 tv502427_ex5-1.htm EX-5.1 32412
4 EXHIBIT 12.1 tv502427_ex12-1.htm EX-12.1 39273
5 EXHIBIT 23.1 tv502427_ex23-1.htm EX-23.1 3180
6 EXHIBIT 23.2 tv502427_ex23-2.htm EX-23.2 2721
7 GRAPHIC tv502427_img01.jpg GRAPHIC 71084
8 GRAPHIC tv502427_img02.jpg GRAPHIC 93745
  Complete submission text file 0001144204-18-048591.txt   1054660
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-227241 | Film No.: 181060793
SIC: 2836 Biological Products, (No Diagnostic Substances)